Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleobindin-1 (NUCB1) is a multidomain calcium-binding protein featuring two EF-hand motifs, a leucine zipper, a DNA-binding region, and a nuclear localization signal[1][3][5][6]. NUCB1 is found in the Golgi apparatus, ER, nucleus, and cytoplasm, where it acts as a calcium sensor, participates in protein trafficking, and regulates signaling pathways—including functioning as a calcium-dependent guanine nucleotide dissociation inhibitor for Gαi subunits of heterotrimeric G proteins[1][3]. NUCB1 also binds to protofibrillar amyloid aggregates from proteins such as Aβ42, α-synuclein, islet amyloid polypeptide, and transthyretin, stabilizing their soluble intermediates and preventing toxic fibril formation—which implicates NUCB1 in neurodegenerative and metabolic diseases as a natural chaperone-like amyloid binding protein[2][3]. In the ER and Golgi, NUCB1 negatively regulates the unfolded protein response, impacting cellular stress reactions[3]. Its structure and multiple interaction domains enable both nucleic acid and protein binding, with emerging evidence of enzymatic activities (e.g., serine protease-like) regulated by interactions with metal ions and G proteins[3][4][6].
N/A—no drugs act directly on NUCB1. Its actions involve protein-protein interactions, inhibitory capping of amyloid protofibrils, and regulation of nucleotide release from Gαi subunits[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleobindin-1 (NUCB1).